STEPHANIE QUACH: Open Payments
NPI 1316488976 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 32 payments from 16 companies in 2025. Trend: 2023 $197 · 2024 $143 · 2025 $904
Food & beverage: $827Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $139 |
| CONMED Corporation | 1 | $110 |
| ABBVIE INC. | 5 | $102 |
| Phathom Pharmaceuticals, Inc. | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Boston Scientific Corporation | 2 | $50 |
| GENZYME CORPORATION | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| QOL Medical, LLC | 1 | $32 |
Products named: TREMFYA, DUPIXENT, CONMED BILIARY, VOQUEZNA, RINVOQ, Bulkamid, XIFAXAN, Sucraid.
Industry payments across FL — which companies pay providers there.
